Evidence map›Paper›PMID 37698553›Full record

ArticleThe Journal of experimental medicine2023

Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in the lung.

Mikel J Rüterbusch, Brian D Hondowicz, Kennidy K Takehara, Kurt B Pruner, Thomas S Griffith, Marion Pepper

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mikel J RüterbuschDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-6619-1175
Brian D HondowiczDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0009-0004-9778-3239
Kennidy K TakeharaDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-1990-155X
Kurt B PrunerDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0001-9530-395X
Thomas S GriffithDepartment of Urology, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-7205-9859
Marion PepperDepartment of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0001-7278-0147
University of Washington · USUniversity of Minnesota · US

Funding

NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
Acquisition of BD FACSymphony A3 Lite Flow CytometerS10OD024979 · OD · UNIVERSITY OF WASHINGTON · PI BLACK, MICHELE C · 2020 to 2020
$344k
NCATS NIH HHS TL1 TR002318NIH HHS S10 OD024979NIH HHS U19 A107422
6 · The paper itself

Abstract

CD4+ lung-resident memory T cells (TRM) generated in response to influenza infection confer effective protection against subsequent viral exposures. Whether these cells can be altered by environmental antigens and cytokines released during heterologous, antigen-independent immune responses is currently unclear. We therefore investigated how influenza-specific CD4+ Th1 TRM in the lung are impacted by a subsequent Th2-inducing respiratory house dust mite (HDM) exposure. Although naïve influenza-specific CD4+ T cells in the lymph nodes do not respond to HDM, influenza-specific CD4+ TRM in the lungs do respond to a subsequent allergen exposure by decreasing expression of the transcription factor T-bet. This functional alteration is associated with decreased IFN-γ production upon restimulation and improved disease outcomes following heterosubtypic influenza challenge. Further investigation revealed that ST2 signaling in CD4+ T cells during allergic challenge is necessary to induce these changes in lung-resident influenza-specific CD4+ TRM. Thus, heterologous antigen exposure or ST2-signaling can drive persistent changes in CD4+ Th1 TRM populations and impact protection upon reinfection.

Indexed as

Influenza, HumanAllergensAnimalsCD4-Positive T-LymphocytesHumansInterleukin-1 Receptor-Like 1 ProteinPyroglyphidaeTh1 CellsAllergensInterleukin-1 Receptor-Like 1 Protein

Identifiers

PMID37698553
PMCPMC10497397
OpenAlexW4386624347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.